Literature DB >> 16442544

Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers.

John B Sacci1, Uzma Alam, Donna Douglas, Jamie Lewis, D Lorne J Tyrrell, Abdu F Azad, Norman M Kneteman.   

Abstract

The exoerythrocytic stage of Plasmodium falciparum has remained a difficult phase of the parasite life-cycle to study. The host and tissue specificity of the parasite requires the experimental infection of humans or non-human primates and subsequent surgical recovery of parasite-infected liver tissue to analyze this stage of the parasites development. This type of study is impossible in humans due to obvious ethical considerations and the cost and complexity in working with primate models has precluded their use for extensive studies of the exoerythrocytic stage. In this study we assessed, for the first time, the use of transgenic, chimeric mice containing functioning human hepatocytes as an alternative for modeling the in vivo interaction of P. falciparum parasites and human hepatocytes. Infection of these mice with P. falciparum sporozoites produced morphologically and antigenically mature liver stage schizonts containing merozoites capable of invading human red blood cells. Additionally, using microdissection, highly enriched P. falciparum liver stage parasites essentially free of hepatocyte contamination, were recovered for molecular studies. Our results establish a stable murine model for P. falciparum that will have a wide utility for assessing the biology of the parasite, potential anti-malarial chemotherapeutic agents and vaccine design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442544     DOI: 10.1016/j.ijpara.2005.10.014

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  40 in total

1.  Study of hepatitis C virus entry in genetically humanized mice.

Authors:  Marcus Dorner; Charles M Rice; Alexander Ploss
Journal:  Methods       Date:  2012-06-08       Impact factor: 3.608

Review 2.  A pre-emptive strike against malaria's stealthy hepatic forms.

Authors:  Dominique Mazier; Laurent Rénia; Georges Snounou
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

3.  Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.

Authors:  Sebastian A Mikolajczak; John B Sacci; Patricia De La Vega; Nelly Camargo; Kelly VanBuskirk; Urszula Krzych; Jun Cao; Marcelo Jacobs-Lorena; Alan F Cowman; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2011-06-24       Impact factor: 3.715

Review 4.  Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections.

Authors:  Alexis Kaushansky; Sebastian A Mikolajczak; Marissa Vignali; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2014-03-06       Impact factor: 3.715

5.  Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection.

Authors:  Benjamin Y Winer; Tiffany Huang; Benjamin E Low; Cindy Avery; Mihai-Alexandru Pais; Gabriela Hrebikova; Evelyn Siu; Luis Chiriboga; Michael V Wiles; Alexander Ploss
Journal:  Virology       Date:  2016-12-19       Impact factor: 3.616

Review 6.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

Review 7.  Malaria Parasite Liver Infection and Exoerythrocytic Biology.

Authors:  Ashley M Vaughan; Stefan H I Kappe
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

8.  Human-animal chimeras for vaccine development: an endangered species or opportunity for the developing world?

Authors:  Anant Bhan; Peter A Singer; Abdallah S Daar
Journal:  BMC Int Health Hum Rights       Date:  2010-05-19

9.  Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection.

Authors:  Lander Foquet; Cornelus C Hermsen; Geert-Jan van Gemert; Eva Van Braeckel; Karin E Weening; Robert Sauerwein; Philip Meuleman; Geert Leroux-Roels
Journal:  J Clin Invest       Date:  2014-01       Impact factor: 14.808

10.  Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design.

Authors:  Kelley M VanBuskirk; Matthew T O'Neill; Patricia De La Vega; Alexander G Maier; Urszula Krzych; Jack Williams; Megan G Dowler; John B Sacci; Niwat Kangwanrangsan; Takafumi Tsuboi; Norman M Kneteman; Donald G Heppner; Brant A Murdock; Sebastian A Mikolajczak; Ahmed S I Aly; Alan F Cowman; Stefan H I Kappe
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.